Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018
Period Ending	Nov '24 Nov 21, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	2018
Market Capitalization	60	90	118	149	70	110	Upgrade
Market Cap Growth	-35.54%	-23.64%	-20.54%	112.60%	-36.02%	-	Upgrade
Enterprise Value	104	131	146	160	74	95	Upgrade
Last Close Price	0.67	1.00	1.35	1.70	0.95	1.55	Upgrade
PE Ratio	11.37	12.86	51.34	-	-	-	Upgrade
PS Ratio	0.79	1.58	3.30	8.75	27.48	52.24	Upgrade
PB Ratio	0.74	1.13	1.77	2.32	1.83	2.19	Upgrade
P/TBV Ratio	0.79	1.13	1.77	2.32	1.83	2.34	Upgrade
P/OCF Ratio	6.54	16.63	-	-	-	-	Upgrade
EV/Sales Ratio	1.35	2.29	4.07	9.40	29.09	45.28	Upgrade
EV/EBITDA Ratio	7.15	7.92	16.91	58.11	-	-	Upgrade
EV/EBIT Ratio	12.06	11.17	30.25	3041.18	-	-	Upgrade
Debt / Equity Ratio	0.60	0.57	0.73	0.33	0.34	0.26	Upgrade
Debt / EBITDA Ratio	3.37	2.75	5.54	7.15	-	-	Upgrade
Asset Turnover	0.54	0.43	0.33	0.23	0.04	0.04	Upgrade
Inventory Turnover	1.41	1.14	1.40	1.39	1.09	-	Upgrade
Quick Ratio	0.65	0.70	1.75	1.63	2.32	5.37	Upgrade
Current Ratio	2.32	2.44	3.46	2.82	3.03	5.47	Upgrade
Return on Equity (ROE)	6.78%	9.48%	3.52%	-2.98%	-29.66%	-40.12%	Upgrade
Return on Assets (ROA)	3.78%	5.48%	2.77%	0.04%	-12.16%	-12.79%	Upgrade
Return on Capital (ROIC)	4.30%	6.09%	3.01%	0.05%	-13.06%	-13.64%	Upgrade
Earnings Yield	8.80%	7.68%	1.95%	-1.03%	-17.81%	-11.24%	Upgrade
FCF Yield	1.91%	-4.91%	-18.20%	-22.26%	-26.41%	-27.77%	Upgrade
Buyback Yield / Dilution	-2.09%	-1.66%	-14.80%	-7.26%	-16.02%	-70.38%	Upgrade
Total Shareholder Return	-2.09%	-1.66%	-14.80%	-7.26%	-16.02%	-70.38%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.